• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Regeneron Pharmaceuticals

Close up image of wooden cubes with alphabet Q1 on office desk - stock photo
Pharma

Led by Lilly, 8 companies reach double-digit revenue gains in Q1

Sales trended upward in the first quarter of this year as eight of the biopharma industry’s top-25 companies had double-digit year-over-year growth.
Kevin Dunleavy May 21, 2026 9:00am
Eylea

Regeneron sees more regulatory issues, sales declines for Eylea

Apr 29, 2026 12:05pm
hearing audio waves

Regeneron ushers in new era with inaugural gene therapy approval

Apr 23, 2026 3:22pm
Regeneron

Regeneron unveils latest drug pricing accord with White House

Apr 23, 2026 2:17pm
Sanofi

Sanofi has 'vigorous defense planned' for Dupixent patent cliff

Apr 23, 2026 1:35pm
Regeneron
Favicon Fierce Biotech

Regeneron rides into radiopharma via $2.1B biobucks Telix pact

Apr 13, 2026 7:24am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings